COOPERS BOVILIS S INACTIVATED SALMONELLA VACCINE FOR CATTLE

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

INACTIVATED SALMONELLA DUBLIN & TYPHIMURIUM ANTIGENS; THIOMERSAL

Available from:

INTERVET AUSTRALIA PTY LIMITED

INN (International Name):

Salmonella dublin+Salmonella typhimurium (inacti

Pharmaceutical form:

MISC. VACCINES OR ANTI SERA

Composition:

INACTIVATED SALMONELLA DUBLIN & TYPHIMURIUM ANTIGENS VACCINE-MICROBIAL Active 0.0 Undefined; THIOMERSAL MERCURY Other 0.1 mg/ml

Units in package:

100mL; 250mL; 50mL

Class:

VM - Veterinary Medicine

Manufactured by:

INTERVET AUSTRALIA

Therapeutic group:

CATTLE | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COW | DAIRY COW | HEIFER | STEER

Therapeutic area:

IMMUNOTHERAPY

Therapeutic indications:

SALMONELLA | INCLUDING B-LACTAMASE PRODUCIN | SALMONELLOSIS

Product summary:

Poison schedule: 0; Withholding period: WHP: Nil.; Host/pest details: CATTLE: [SALMONELLA]; Poison schedule: 0; Withholding period: ; Host/pest details: CATTLE: [SALMONELLA]; An aid in the control of cattle salmonellosis caused by Salmonella dublin and S. typhimurium.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

COOPERS BOVILIS S INACTIVATED SALMONELLA VACCINE FOR CATTLE
49960/130198
Product Name:
APVMA Approval Number:
Label Name:
COOPERS BOVILIS S INACTIVATED SALMONELLA VACCINE FOR CATTLE
Signal Headings:
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
Inactivated Salmonella dublin: minimum input 2.5 x 10^8 orgs/mL.
Inactivated Salmonella typhimurium: minimum input 2.5 x 10^8 orgs/mL.
Also contains:
0.1 mg/mL Thiomersal (preservative).
Claims:
An aid in the control of cattle salmonellosis caused by Salmonella
dublin and Salmonella
typhimurium.
Net Contents:
100mL
250mL
50mL
Directions for Use:
Restraints:
Contraindications:
Precautions:
Side Effects:
Dosage and
Administration:
Shake well to mix before use and keep mixed during use.
USE ALL PRODUCT WITHIN 12 HOURS OF OPENING.
Inject healthy cattle with 2 mL subcutaneously. The recommended site
of injection is that
used for routine injection in cattle i.e. under the skin in the neck.
VACCINATION PROGRAM
It is recommended that cows should be vaccinated twice with a 2 mL
subcutaneous
injection 3 to 4 weeks apart. Then a booster dose is given every 12
months. For colostral RLP APPROVED
protection, vaccinate pregnant cows approximately 8 and 3 weeks before
calving. Calves
should be fed colostrum from vaccinated cows for at least 5 days after
birth.
METHOD OF VACCINATION
1. Use sterile equipment or commercially available sterile equipment.
2. Avoid injection of animals under wet or dusty conditions, if
possible.
3. Before vaccine is injected the proposed site of vaccination may be
cleansed by swabbing
with cotton wool dipped in antiseptic.
4. Use needles of appropriate length and gauge i.e. 16 gauge 15 mm. We
recommend you
obtain disposable needles from your Veterinarian. Replace them
frequently while
vaccinating.
5. Maintain cleanliness at all times during vaccination. Take care to
avoid contamination of
the vaccine, needles and internal parts of the syringe by contact with
non-sterile surfaces or
dirty hands. Poor techniques can cause abscesses or illness in the
cow.
6. M

Summary of Product characteristics

PRODUCT NAME: BOVILIS® S INACTIVATED SALMONELLA VACCINE FOR
CATTLE
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY, 2009
PAGE: 1 OF 6
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Inactivated Salmonella typhimurium and Salmonella dublin vaccine.
TRADE NAME:
BOVILIS
® S INACTIVATED SALMONELLA VACCINE FOR CATTLE
PRODUCT CODE:
3754B ( 250mL ) and 3754C ( 100mL )
RECOMMENDED USE:
A vaccine (_Salmonella typhimurium_ and _Salmonella dublin_), for use
as an aid in the
control of cattle Salmonellosis.
APVMA NO:
49960
CREATION DATE:
November, 2006
THIS VERSION ISSUED:
July, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S45. In case of accident or if you feel unwell, contact a doctor or
Poisons Information Centre
immediately (show the label where possible).
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
Off-white milky liquid.
ODOUR:
No odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. In addition
product is unlikely to
cause any discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. In addition product is unlikely to cause any discomfort in
normal use.
LONG TERM EXPOSURE:
No data for health effects associated with long term skin exposure.
EYE CONTACT:
POTENTI